Delivery Order SPE2DR25D3015-SPE2DR26F4FQ8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,005.80 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. The award, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this order. As a major pharmaceutical distributor and critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,499.68 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen (0.5 ml), a diabetes medication, with a completion date of November 4, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,809.48 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. The award was made on November 20, 2025, with an ultimate completion date of November 21, 2025, under firm fixed price terms with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,360.45 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. The contract was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, and is classified as a firm fixed price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $8,123.67 delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen (0.5 ml), a diabetes medication, with an ultimate completion date of November 28, 2025. This is a firm fixed-price delivery order under a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement supporting military and...
- The Defense Logistics Agency awarded a delivery order valued at $10,810.00 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen (0.5ml), a diabetes medication. The contract is a firm fixed-price delivery order with an ultimate completion date of December 3, 2025, and was competitively awarded without set-aside provisions. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,176.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pen (0.5 mL), a diabetes medication. The award was made on April 23, 2025, with an ultimate completion date of April 24, 2025, and represents a non-competitive delivery order under the company's existing contract vehicle. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,632.54 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The contract was awarded on October 21, 2025, with an ultimate completion date of October 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,580.52 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pens on November 13, 2025, with completion expected by November 14, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded procurement of this diabetes medication from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $1,818.39 delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pen (0.5 mL), a diabetes medication, with an ultimate completion date of December 19, 2025. This non-set-aside, competitively awarded contract utilized firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with the agency. The product will be delivered to AmerisourceBergen's corporate office location in...
- SPE2DR25D3015Indefinite Delivery Contract
- SPE2DR25D3015-SPE2DR26F4FQ8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,672.73 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen (0.5 ml), a diabetes medication, with an ultimate completion date of December 22, 2025. This non-set-aside, competitively awarded contract utilized firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger federal contract vehicle. The product will be delivered to the company's Conshohocken, Pennsylvania location, which serves as the prime distributor's headquarters and place of performance. This delivery order is executed under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 through December 2026. The parent IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including support for the Defense Health Agency and other federal healthcare systems. The company's established role as a major pharmaceutical distributor positions it to fulfill critical medication needs across multiple therapeutic domains for federal medical procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 12/18/25 |